SCHEMBL3665766

SCHEMBL3665766

FC(F)(F)c1ccnc(Oc2ccccc2)n1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
BLM P54132 1/20 0.47
ALOX5AP P20292 3/20 0.44
FEN1 P39748 3/20 0.44
MAPK8 P45983 1/20 0.43
SYK P43405 3/20 0.42
RAB9A P51151 1/20 0.41
TAS2R14 Q9NYV8 1/20 0.40
LOX P28300 1/20 0.40
LOXL2 Q9Y4K0 1/20 0.40
MAPT P10636 2/20 0.40
HSD17B10 Q99714 1/20 0.40
PKM P14618 1/20 0.39
SCN9A Q15858 1/20 0.38
MEN1 O00255 1/20 0.38
APAF1 O14727 1/20 0.38
KMT2A Q03164 1/20 0.38
CYP1A2 P05177 1/20 0.37
CYP2C9 P11712 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15271000 0.83 ALOX5AP (0.38) BLMALOX5APFEN1SYKMAPT
SCHEMBL14994045 0.82 SYK (0.46) MAPK8SYKRAB9ATAS2R14LOXL2
SCHEMBL24156355 0.81 BLM (0.46) BLMALOX5APFEN1SYKRAB9A
SCHEMBL15271835 0.80 ALDH1A1 (0.59) ALOX5APFEN1MAPTSCN9ACYP2C9
SCHEMBL3665651 0.80 PTGS1 (0.43) ALOX5APFEN1SYKMAPTPKM
SCHEMBL15916131 0.78 ALOX5AP (0.49) BLMALOX5APFEN1SYKRAB9A
SCHEMBL9900953 0.77 SCN9A (0.35) ALOX5APFEN1SYKMAPTSCN9A
SCHEMBL7469883 0.77 MAPK8 (0.46) MAPK8RAB9ALOXL2MAPTSCN9A
SCHEMBL15270981 0.76 ALOX5AP (0.41) BLMALOX5APFEN1SYKTAS2R14
SCHEMBL7074202 0.76 SYK (0.44) ALOX5APFEN1SYKRAB9ALOX

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8299262-B2 Pyridylmethyl-sulfonamide compounds BASF SE (DE) 2012-10-30 US disclosed
US-20100249077-A1 Pyridylmethyl-Sulfonamide Compounds BASF SE (DE) 2010-09-30 US disclosed
EP-2231605-A1 PYRIDYLMETHYL-SULFONAMIDE COMPOUNDS BASF SE (DE) 2010-09-29 EP disclosed
WO-2009071449-A1 PYRIDYLMETHYL-SULFONAMIDE COMPOUNDS BASF SE (DE) 2009-06-11 WO disclosed
WO-2009071448-A1 PYRIDYLMETHYL-SULFONAMIDE COMPOUNDS BASF SE (DE) 2009-06-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249077-A1 Pyridylmethyl-Sulfonamide Compounds CBR3, CBR1, CBS BLM 4594/4885ALOX5AP 388/4885FEN1 3277/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.